Projects per year
Fingerprint
- 1 Similar Profiles
Collaborations and top research areas from the last five years
-
Reversible Covalent BTK Degraders as the Next Generation Targeted Therapy to Treat B-cell Malignancies
Wang, J. (PI), Woyach, J. A. (CoPI) & Wang, M. M. (CoPI)
07/1/20 → 06/30/25
Project: Research
-
Improving BTK Directed Therapy for CLL
Woyach, J. A. (PI) & Johnson, A. J. (CoPI)
07/1/15 → 06/30/21
Project: Research
-
Dual targeting of XPO1 and BTK in B cell malignancies
Lapalombella, R. (PI), Blum, K. A. (CoPI), Byrd, J. C. (CoPI) & Woyach, J. A. (CoPI)
04/21/15 → 03/31/21
Project: Research
-
Molecular Evaluation of Targeted Therapies in Lymphoid Malignancies
Byrd, J. C. (PI), Johnson, A. J. (CoPI) & Woyach, J. A. (CoPI)
01/1/14 → 12/31/19
Project: Research
-
Targeted Therapies and Mechanisms of Resistance in Chronic Lymphocytic Leukemia
Woyach, J. A. (PI)
09/17/13 → 08/31/18
Project: Research
-
LP-118 is a novel B-cell lymphoma 2 / extra-large inhibitor that demonstrates efficacy in models of venetoclax-resistant chronic lymphocytic leukemia
Ravikrishnan, J., Diaz-Rohena, D. Y., Muhowski, E., Mo, X., Lai, T. H., Misra, S., Williams, C. D., Sanchez, J. R., Mitchell, A., Satpati, S., Perry, E., Kaufman, T., Liu, C., Lozanski, A., Lozanski, G., Rogers, K. A., Kittai, A. S., Bhat, S. A., Collins, M. C. & Davids, M. S. & 11 others, , Jan 2025, In: Haematologica. 110, 1, p. 78-91 14 p.Research output: Contribution to journal › Article › peer-review
Open Access1 Scopus citations -
Predictive ability of the Cancer and Aging Research Group chemotherapy toxicity calculator in hematologic malignancy
Rosko, A. E., Huang, Y., Wall, S. A., Mims, A., Woyach, J., Presley, C., Williams, N. O., Stevens, E., Han, C. J., Von Ah, D., Islam, N., Krok-Schoen, J. L., Burd, C. E. & Naughton, M. J., Jan 2025, In: Journal of Geriatric Oncology. 16, 1, 102144.Research output: Contribution to journal › Article › peer-review
1 Scopus citations -
SOHO State of the Art Updates and Next Questions | Covalent Bruton's Tyrosine Kinase Inhibitors in Chronic Lymphocytic Leukemia
Alsouqi, A. & Woyach, J. A., Feb 2025, In: Clinical Lymphoma, Myeloma and Leukemia. 25, 2, p. 89-95 7 p.Research output: Contribution to journal › Review article › peer-review
-
Targeting WDR5/ATAD2 signaling by the CK2/IKAROS axis demonstrates therapeutic efficacy in T-ALL
Han, Q., Gu, Y., Xiang, H., Zhang, L., Wang, Y., Yang, C., Li, J., Steiner, C., Lapalombella, R., Woyach, J. A., Yang, Y., Dovat, S., Song, C. & Ge, Z., 2025, (Accepted/In press) In: Blood.Research output: Contribution to journal › Article › peer-review
1 Scopus citations -
The challenge of targeting key drivers of CLL and sequencing therapy in an era of experimental therapeutics
Gordon, B. K. & Woyach, J. A., 2025, (Accepted/In press) In: Leukemia and Lymphoma.Research output: Contribution to journal › Review article › peer-review